Imaging3 (OTCQB: IGNG), together with Los Angeles-based privately held cannabis company Grapefruit Boulevard Investments, Inc. (“GBI”), this morning announced that it has retained outside counsel to assist in the preparation of a registration statement to register shares of IGNG’s common stock underlying the convertible note recently issued by the company to an institutional investor. Per the update, the second tranche of $1,400,000.00 is required to be paid by the investor on the day the registration statement is filed with the SEC. “We intend to file our registration statement as soon as practicable in order to expedite our receipt of additional funding from our investor and accelerate our growth to the best of our ability. The selection of outside counsel renews our commitment to filing the registration statement as expeditiously as possible, but no guarantee can be made that the registration statement will be filed or that it will be declared effective by the SEC. We move inexorably toward our goal of becoming a leading fully integrated cannabis company,” Imaging3 CEO Bradley J. Yourist stated in the news release.
To view the full press release, visit http://cnw.fm/2nPy7
About Imaging3, Inc.
Imaging3, Inc., founded in 1993, has developed a patented medical imaging technology, called the Dominion SmartScan(TM), that produces 3D X-ray images, effectively in real time. The SmartScan technology has the potential to allow healthcare professionals to perform diagnostic and therapeutic procedures more quickly and accurately, which may result in higher throughput for the clinicians and fewer safety risks for patients. Imaging3’s technology exposes patients to less harmful radiation than current equivalent imaging technologies such as CT scans. The company believes this will allow scans to be used in many settings where scanning is currently limited by concerns about radiation exposure. The technology also notably allows for reasonably convenient portability, easier installation and use-readiness, and a significantly reduced cost burden suitable for novel settings and for healthcare systems across varied global settings. Imaging3 plans to submit a 510(k) application to FDA during 2019 and or 2020 to gain marketing authorization for initial applications for the SmartScan technology. For more information, visit the company’s website at www.Imaging3.com.
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cannabisnewswire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
